Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 211

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Data Withholding in Genetics and the Other Life Sciences: Prevalences and Predictors

Blumenthal, David, Campbell, Eric G., Gokhale, Manjusha, Yucel, Recai, Clarridge, Brian, Hilgartner, Stephen, Holtzman, Neil A. · 2006 · Academic Medicine

Abstract

A productive and ethical relationship between the pharmaceutical industry and physicians is critical to improving drug discovery and public health. In response to concerns about inappropriate financial relationships between the pharmaceutical industry and physicians, national organizations representing physicians or industry have made recommendations designed to reduce conflicts of interest, legal exposure, and dissemination of biased information. Despite these initiatives, the prescribing practices of physicians may be unduly influenced by the marketing efforts of industry and physicians may inadvertently distribute information that is biased in favor of a commercial entity. Moreover, physicians may be vulnerable to prosecution through federal anti-kickback and false claims statutes because of potentially inappropriate financial relationships with pharmaceutical companies. Since academic medical centers have a critical role in establishing professional standards, the faculty of Yale University School of Medicine developed guidelines for the relationships of faculty with the pharmaceutical industry, which were approved in May 2005. Input from clinical faculty and from representatives of the pharmaceutical industry was utilized in formulating the guidelines. In contrast to existing recommendations, the Yale guidelines, which are presented as an Appendix here, ban faculty from receiving any form of gift, meal, or free drug sample (for personal use) from industry, and set more stringent standards for the disclosure and resolution of financial conflict of interest in Yale's educational programs. The growing opportunities for drug discovery, the need to use medications in a more evidence-based manner, and preservation of the public trust require the highest professional standards of rigor and integrity. These guidelines are offered as part of the strategy to meet this compelling challenge.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00001888-200602000-00008

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 10

  1. Blumenthal, 1997, JAMA, 277, 1224, 10.1001/jama.1997.03540390054035 · DOI · Paper page
  2. Campbell, 1998, JAMA, 279, 995, 10.1001/jama.279.13.995 · DOI
  3. Campbell, 2002, JAMA, 287, 473, 10.1001/jama.287.4.473 · DOI · Paper page
  4. Cohen, 1995, Science, 268, 1715, 10.1126/science.7792594 · doi:10.1126/science.7792594
  5. Blumenthal, 1996, N Engl J Med, 334, 368, 10.1056/NEJM199602083340606 · DOI · Paper page
  6. Blumenthal, 1996, N Engl J Med, 335, 1734, 10.1056/NEJM199612053352305 · DOI · Paper page
  7. Campbell, 2000, Res Policy, 29, 303, 10.1016/S0048-7333(99)00068-2 · DOI · Paper page
  8. Berhdahl, 2005, Group Dynam Theory Res Practice, 9, 45, 10.1037/1089-2699.9.1.45 · DOI
  9. Vogeli, 2006, Acad Med, 81, 128, 10.1097/00001888-200602000-00007 · DOI
  10. Holtzman, 2006, Commun Genet, 9, &NA;

Cited by

See all 211

Metadata

Authors
Blumenthal, D., Campbell, E. G., Gokhale, M., Yucel, R., Clarridge, B., Hilgartner, S., & Holtzman, N. A.
Venue
Academic Medicine
Published
2006-02
Volume
81
Issue
2
Pages
137-145
ISSN
1040-2446 (ISSN-L)
OpenAlex
W2087685293
Cited by
211
References
4
FWCI
13.98
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Data Withholding in Genetics and the Other Life Sciences: Prevalences and Predictors. https://app.cochat.ai/papers/10.1097/00001888-200602000-00008
The paper
Blumenthal, D., Campbell, E. G., Gokhale, M., Yucel, R., Clarridge, B., Hilgartner, S., & Holtzman, N. A. (2006). Data Withholding in Genetics and the Other Life Sciences: Prevalences and Predictors. Academic Medicine. https://doi.org/10.1097/00001888-200602000-00008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.